Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2018

01-01-2018 | Brief Communication

Major Gastric Haemorrhage After Intragastric Balloon Insertion: Case Report

Authors: Romy J. Granek, Michael W. Hii, Salena M. Ward

Published in: Obesity Surgery | Issue 1/2018

Login to get access

Abstract

Intragastric balloons are a minimally invasive option for weight loss. They are generally well tolerated and rarely associated with serious adverse events. We report a case of major upper gastrointestinal haemorrhage after insertion of an Orbera® intragastric balloon.
Literature
1.
Australian Bureau of Statistics. National Health Survey: first results, 2014-15. Canberra (AU); 2015. ABS Cat. no. 4364.0.
2.
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011 Jul;34(7):1481–6.CrossRefPubMedPubMedCentral
3.
Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;(8):CD003641.
4.
Zheng Y, Wang M, He S, et al. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med. 2015;13:246.CrossRefPubMedPubMedCentral
5.
Yorke E, Switzer NJ, Reso A, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26:2248–54.CrossRefPubMed
6.
Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther. 2017;34(8):1859–187.
7.
Evans JT, DeLegge MH. Intragastric balloon therapy in the management of obesity: why the bad wrap? JPEN J Parenter Enteral Nutr. 2011;35(1):25–31.CrossRefPubMed
8.
Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011 Oct;21(10):1499–507.CrossRefPubMedPubMedCentral
9.
ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38.CrossRef
10.
Dumonceau J. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–7.CrossRefPubMed
11.
Fernandes M, Atallah AN, Soares BG, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1):CD004931.
12.
Matar ZS, Mohamed AA, Abukhater M, et al. Small bowel obstruction due to air-filled intragastric balloon. Obes Surg. 2009 Dec;19(12):1727–30.CrossRefPubMed
13.
14.
Mottet C, Juillerat P, Pittet V, et al. Upper gastrointestinal Crohn’s disease. Digestion. 2007;76(2):136–40.CrossRefPubMed
15.
Ikeuchi H, Hori K, Nishigami T, et al. Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis. World J Gastroenterol. 2006;12(36):5913–5.CrossRefPubMedPubMedCentral
16.
Charalambous MP, Thompson J, Efthimiou E. Late gastric perforation after insertion of intragastric balloon for weight loss—video case report and literature review. Surg Obes Relat Dis. 2012;8(1):121–3.CrossRefPubMed
17.
Sánchez-Pérez MA, Muñoz-Juárez M, Cordera-González de Cosío F, et al. Gastric perforation and subarachnoid hemorrhage secondary to intragastric balloon device. Rev Gastroenterol Mex. 2011;76(3):264–9.PubMed
18.
Göttig S, Daskalakis M, Weiner S, et al. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg. 2009 Jun;19(6):677–83.CrossRefPubMed
19.
Kumar N, Bazerbachi F, Rustagi T, et al. The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2272–2278.
Metadata
Title
Major Gastric Haemorrhage After Intragastric Balloon Insertion: Case Report
Authors
Romy J. Granek
Michael W. Hii
Salena M. Ward
Publication date
01-01-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2988-8

Other articles of this Issue 1/2018

Obesity Surgery 1/2018 Go to the issue

Letter to Editor/LED Reply

Chronic Disease Model of Shared Care after Obesity and Metabolic Surgery

Brief Communication

Increased Free Testosterone Levels in Men with Uncontrolled Type 2 Diabetes Five Years After Randomization to Bariatric Surgery

Original Contributions

The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery

Biography

John Melissas, MD, PhD, FACS

Original Contributions

Inversion Technique for the Removal of Partially Covered Self-Expandable Metallic Stents

Original Contributions

A Randomized Comparison Between Staple-Line Oversewing Versus No Reinforcement During Laparoscopic Vertical Sleeve Gastrectomy